Clinical trial
Study of Diroximel Fumarate in the Real-World Setting
NCT04746976
Study timeline
Study start (actual)2021-03-01Date precision: day
Registry last updated2023-05-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Forms of MSunresolved
Interventions
Diroximel FumarateDRUG · verified · RxNorm: diroximel fumarate
Sponsors & collaborators
Biogenlead sponsor
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1LouisvilleKentucky, United States1Kansas CityMissouri, United States1BuffaloNew York, United States1SpokaneWashington, United States1KnoxvilleTennessee, United States1GreensboroNorth Carolina, United States1DanvillePennsylvania, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04746976 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.